LDHA and breast carcinoma: As the expression of DIO3OS increases in breast cancer cells undergoing AI resistance, the aberrant activation of DIO3OS/PTBP1/LDHA glycolysis cascade may endow tumor cells with metabolic adaptation that allows them to survive from AI-caused estrogen deficiency.